Cargando…
Efficacy and Safety of Sonidegib in Adult Patients with Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome): Results from a Phase 2, Double-Blind, Randomized Trial
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008063/ https://www.ncbi.nlm.nih.gov/pubmed/32104037 http://dx.doi.org/10.2147/CCID.S233097 |
| _version_ | 1783495411179192320 |
|---|---|
| author | Lear, John T Hauschild, Axel Stockfleth, Eggert Squittieri, Nicholas Basset-Seguin, Nicole Dummer, Reinhard |
| author_facet | Lear, John T Hauschild, Axel Stockfleth, Eggert Squittieri, Nicholas Basset-Seguin, Nicole Dummer, Reinhard |
| author_sort | Lear, John T |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7008063 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Dove |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-70080632020-02-26 Efficacy and Safety of Sonidegib in Adult Patients with Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome): Results from a Phase 2, Double-Blind, Randomized Trial Lear, John T Hauschild, Axel Stockfleth, Eggert Squittieri, Nicholas Basset-Seguin, Nicole Dummer, Reinhard Clin Cosmet Investig Dermatol Research Letter Dove 2020-02-03 /pmc/articles/PMC7008063/ /pubmed/32104037 http://dx.doi.org/10.2147/CCID.S233097 Text en © 2020 Lear et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
| spellingShingle | Research Letter Lear, John T Hauschild, Axel Stockfleth, Eggert Squittieri, Nicholas Basset-Seguin, Nicole Dummer, Reinhard Efficacy and Safety of Sonidegib in Adult Patients with Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome): Results from a Phase 2, Double-Blind, Randomized Trial |
| title | Efficacy and Safety of Sonidegib in Adult Patients with Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome): Results from a Phase 2, Double-Blind, Randomized Trial |
| title_full | Efficacy and Safety of Sonidegib in Adult Patients with Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome): Results from a Phase 2, Double-Blind, Randomized Trial |
| title_fullStr | Efficacy and Safety of Sonidegib in Adult Patients with Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome): Results from a Phase 2, Double-Blind, Randomized Trial |
| title_full_unstemmed | Efficacy and Safety of Sonidegib in Adult Patients with Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome): Results from a Phase 2, Double-Blind, Randomized Trial |
| title_short | Efficacy and Safety of Sonidegib in Adult Patients with Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome): Results from a Phase 2, Double-Blind, Randomized Trial |
| title_sort | efficacy and safety of sonidegib in adult patients with nevoid basal cell carcinoma syndrome (gorlin syndrome): results from a phase 2, double-blind, randomized trial |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008063/ https://www.ncbi.nlm.nih.gov/pubmed/32104037 http://dx.doi.org/10.2147/CCID.S233097 |
| work_keys_str_mv | AT learjohnt efficacyandsafetyofsonidegibinadultpatientswithnevoidbasalcellcarcinomasyndromegorlinsyndromeresultsfromaphase2doubleblindrandomizedtrial AT hauschildaxel efficacyandsafetyofsonidegibinadultpatientswithnevoidbasalcellcarcinomasyndromegorlinsyndromeresultsfromaphase2doubleblindrandomizedtrial AT stockfletheggert efficacyandsafetyofsonidegibinadultpatientswithnevoidbasalcellcarcinomasyndromegorlinsyndromeresultsfromaphase2doubleblindrandomizedtrial AT squittierinicholas efficacyandsafetyofsonidegibinadultpatientswithnevoidbasalcellcarcinomasyndromegorlinsyndromeresultsfromaphase2doubleblindrandomizedtrial AT bassetseguinnicole efficacyandsafetyofsonidegibinadultpatientswithnevoidbasalcellcarcinomasyndromegorlinsyndromeresultsfromaphase2doubleblindrandomizedtrial AT dummerreinhard efficacyandsafetyofsonidegibinadultpatientswithnevoidbasalcellcarcinomasyndromegorlinsyndromeresultsfromaphase2doubleblindrandomizedtrial |